Medicare, UnitedHealth
Digest more
Medicare Advantage is an $84 billion boondoggle, and one of the simplest, most obvious examples of “waste, fraud and abuse” in the federal government. (That’s not me talking, by the way. That’s the independent Medicare Payment Advisory Commission,
The order is based on a "most favored nation" pricing model, which is similar to a policy Trump pushed in his first administration.
The U.S. Centers for Medicare and Medicaid Services (CMS) said on Monday that it would announce a list of 15 drugs eligible for a third round of Medicare price negotiations by early February next year.
Under the Medicare Drug Price Negotiation Program, the HHS secretary negotiates directly with manufacturers on the prices Medicare will pay for pharmaceuticals.
The Social Security and Medicare Fair Share Act proposes targeting payroll tax loopholes for high-income earners.
Explore more
The Centers for Medicare & Medicaid Services May 12 released draft guidance for the third round of negotiations for the Medicare Drug Price Negotiation Program. The guidance includes policies incorporating drugs payable under Medicare Part B into the program for the first time and is soliciting comments on how to facilitate access to any negotiated maximum fair price for Part B drugs.
During a Congressional hearing held Wednesday, U.S. Department of Health & Human Services (HHS) Secretary Robert F. Kennedy Jr. defended the Trump
How to think about the best ways to utilize your retirement and health care benefits when you may be older, or younger, than your spouse.
Americans pay significantly more for prescription medications, with branded drugs in the U.S. costing about three times more than those in other countries.